Skip to content

Common Stock at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$11K+10.0%
Biogen logo
BiogenBIIB
$100K0.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
220M0.0%
Insmed logo
InsmedINSM
$2.17M+19.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$16K+45.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$3K+50.0%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$910.66M+135%
Enterprise value$634.23M+223%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s common stock?
Solid Biosciences Inc. (SLDB) reported common stock of $98K in Q1 2026.
How has Solid Biosciences Inc.'s common stock changed year-over-year?
Solid Biosciences Inc.'s common stock increased by 27.3% year-over-year, from $77K to $98K.
What is the long-term trend for Solid Biosciences Inc.'s common stock?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s common stock has grown at a -1.9% compound annual growth rate (CAGR), from $87K to $79K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).